NCT03232710View on ClinicalTrials.gov

Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition

NAUnknownINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 26, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

June 30, 2018

Conditions
Bioequivalence
Interventions
DRUG

Bosiqing

Aripiprazole Orally disintegrating tablets 10mg

DRUG

abilify

Aripiprazol orodispersible tablets 10mg

Trial Locations (1)

610000

RECRUITING

West China Hospital of Sichuan University, Chengdu

Sponsors
All Listed Sponsors
lead

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT03232710 - Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition | Biotech Hunter | Biotech Hunter